At the World Orphan Drug Congress USA in April 2017, we are bringing together more than 150 elite speakers to educate and inspire our 1,000 attendees from big pharma, biotech, payers, patient groups, academics and government bodies. In 2017, World Orphan Drug Congress USA is bringing together the worlds of Scientific Innovation and Commercialization, with 2 tracks in the main conference.
By exploring trends in Digital Health, Biosimilars, Gene Therapy, and more, we will uncover the next scientific breakthrough. Examinations of Mergers, Commercialization, Marketing and the Regional Markets will provide insight into this billion-dollar business. That's not all with Rare Disease Advocacy World and Pitch and Partner 2017, there are 4 tracks of content for you and your team to enjoy.
Enjoy discussions on:
FUTURE OF ORPHAN DRUGS
PRICING & REIMBURSEMENT
APPROVAL & ACCESS
M&A AND COMMERCIALIZATION
MARKETING & COMPETITIVENESS
REGIONAL MARKET ANALYSIS
The World Orphan Drug Congress USA is a place where innovation and expertise is showcased, solutions are found and learning is done.
If you offer a solution or product in the orphan drug space, the World Orphan Drug Congress USA is definitely the right place to do this.
Enter your email address